[go: up one dir, main page]

AP564A - Polymer coated tablet comprising amoxycillin and clavulanate. - Google Patents

Polymer coated tablet comprising amoxycillin and clavulanate. Download PDF

Info

Publication number
AP564A
AP564A APAP/P/1995/000733A AP9500733A AP564A AP 564 A AP564 A AP 564A AP 9500733 A AP9500733 A AP 9500733A AP 564 A AP564 A AP 564A
Authority
AP
ARIPO
Prior art keywords
tablet
amoxycillin
clavulanate
tablet formulation
formulation according
Prior art date
Application number
APAP/P/1995/000733A
Other languages
English (en)
Other versions
AP9500733A0 (en
Inventor
Creighton Pierce Conley
Nigel Philip Mccreath Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP564(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP9500733A0 publication Critical patent/AP9500733A0/xx
Application granted granted Critical
Publication of AP564A publication Critical patent/AP564A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
APAP/P/1995/000733A 1994-04-23 1995-04-13 Polymer coated tablet comprising amoxycillin and clavulanate. AP564A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
AP9500733A0 AP9500733A0 (en) 1995-04-30
AP564A true AP564A (en) 1996-11-21

Family

ID=10754044

Family Applications (2)

Application Number Title Priority Date Filing Date
APAP/P/1995/000733A AP564A (en) 1994-04-23 1995-04-13 Polymer coated tablet comprising amoxycillin and clavulanate.
APAP/P/1996/000868A AP9600868A0 (en) 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate.

Family Applications After (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000868A AP9600868A0 (en) 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate.

Country Status (35)

Country Link
US (1) US6051255A (fr)
EP (5) EP1093813B1 (fr)
JP (1) JP3622975B2 (fr)
CN (1) CN1134258C (fr)
AP (2) AP564A (fr)
AT (6) ATE223706T1 (fr)
AU (1) AU684949B2 (fr)
BG (1) BG62842B1 (fr)
BR (1) BR9507502A (fr)
CA (1) CA2188496A1 (fr)
CZ (2) CZ294168B6 (fr)
DE (5) DE69519093T2 (fr)
DK (4) DK1093813T3 (fr)
DZ (1) DZ1876A1 (fr)
ES (4) ES2152485T3 (fr)
FI (1) FI964249L (fr)
GB (1) GB9408117D0 (fr)
GR (2) GR3035031T3 (fr)
HK (1) HK1050992A1 (fr)
HU (1) HU228399B1 (fr)
IL (1) IL113433A (fr)
MA (1) MA23528A1 (fr)
MY (1) MY115351A (fr)
NO (1) NO310703B1 (fr)
NZ (1) NZ285080A (fr)
OA (1) OA10377A (fr)
PL (1) PL316966A1 (fr)
PT (4) PT1093813E (fr)
RO (1) RO116997B1 (fr)
RU (1) RU2152213C1 (fr)
SA (1) SA95160343B1 (fr)
SI (1) SI0758235T1 (fr)
SK (1) SK282594B6 (fr)
WO (1) WO1995028927A1 (fr)
ZA (1) ZA953236B (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ES2165997T3 (es) 1995-09-07 2002-04-01 Smithkline Beecham Plc Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
AU6496498A (en) * 1997-02-07 1998-08-26 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
ATE243516T1 (de) * 1997-02-14 2003-07-15 Glaxosmithkline Lab Sas Amoxicillin und clavulanat enthaltende arzneizubereitungen
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
AU9540898A (en) * 1997-08-29 1999-03-22 Dsm N.V. Granules free of excipients
JP2001521910A (ja) 1997-10-31 2001-11-13 モンサント カンパニー ゲランガム錠剤コーティング
CA2364342C (fr) 1999-04-01 2011-02-01 Dsm N.V. Agglomerats obtenus par cristallisation
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
EP1270005A3 (fr) * 1999-04-13 2006-05-17 Beecham Pharmaceuticals (Pte) Limited Formulation comprenant de l'amoxicilline et un acide organique
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
EP1330236A2 (fr) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
PT1377276E (pt) * 2001-04-10 2011-12-30 Sun Pharma Advanced Res Co Ltd Composição de libertação temporizada por pulso
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003066053A1 (fr) * 2002-02-07 2003-08-14 Rutgers, The State University Polymeres antibiotiques
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
AU2003202058B2 (en) * 2002-02-14 2009-05-28 Glaxo Group Limited Pharmaceutical composition comprising N- ((1-N-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2H- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (fr) * 2002-10-04 2003-09-30 Duchesnay Inc. Mode de preparation de formes posologiques pharmaceutiques contenant de multiples principes actifs
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (fr) * 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In Antibiotique, utilisation et formulation associees
CA2535780A1 (fr) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Produit antibiotique, son utilisation et sa formulation
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
CA2538064C (fr) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
EP1701705A4 (fr) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Absorption amelioree de formes de dosage a liberation modifiee
ES2353309T3 (es) 2004-03-08 2011-03-01 Prosidion Ltd. Hidrazidas del ácido pirrolopiridin-2-carboxílico como inhibidores de glucógeno fosforilasa.
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
TWI367755B (en) 2005-05-20 2012-07-11 Sankyo Co Film coated product
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
ES2625731T3 (es) * 2009-09-18 2017-07-20 Sanofi Formulaciones de tabletas de la (Z)-(4¿-trifluorometilfenil)-amida del ácido 2-ciano-3-hidroxi-but-2-enoico con estabilidad mejorada
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232005A (en) * 1975-04-14 1980-11-04 Beecham Group Limited Antibacterial agents
US4441609A (en) * 1977-10-11 1984-04-10 Beecham Group Limited Pharmaceutical compositions
US4537887A (en) * 1980-09-27 1985-08-27 Beecham Group Limited Pharmaceutical formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
EP1270005A3 (fr) * 1999-04-13 2006-05-17 Beecham Pharmaceuticals (Pte) Limited Formulation comprenant de l'amoxicilline et un acide organique
EP1330236A2 (fr) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232005A (en) * 1975-04-14 1980-11-04 Beecham Group Limited Antibacterial agents
US4441609A (en) * 1977-10-11 1984-04-10 Beecham Group Limited Pharmaceutical compositions
US4537887A (en) * 1980-09-27 1985-08-27 Beecham Group Limited Pharmaceutical formulation

Also Published As

Publication number Publication date
BG62842B1 (bg) 2000-09-29
EP1093813B1 (fr) 2002-10-16
NZ285080A (en) 1998-05-27
DE69528608D1 (de) 2002-11-21
DE69528204T2 (de) 2003-08-07
CN1134258C (zh) 2004-01-14
HK1027024A1 (en) 2001-01-05
EP0978276B1 (fr) 2002-09-11
DE69528608T2 (de) 2003-06-26
GB9408117D0 (en) 1994-06-15
CN1149829A (zh) 1997-05-14
AP9500733A0 (en) 1995-04-30
EP0978276A2 (fr) 2000-02-09
ES2180251T3 (es) 2003-02-01
EP1243267A2 (fr) 2002-09-25
IL113433A (en) 2003-06-24
OA10377A (en) 2001-11-21
HK1050992A1 (en) 2003-07-18
IL113433A0 (en) 1995-07-31
DE69519093D1 (de) 2000-11-16
ES2161288T3 (es) 2001-12-01
CZ11376U1 (cs) 2001-07-12
AT5349U1 (de) 2002-06-25
DE69521799D1 (de) 2001-08-23
HK1021860A1 (en) 2000-07-07
ATE196845T1 (de) 2000-10-15
FI964249A0 (fi) 1996-10-22
PT758235E (pt) 2001-10-31
RU2152213C1 (ru) 2000-07-10
DK0758235T3 (da) 2001-10-29
CZ309096A3 (en) 1997-04-16
EP0758235B1 (fr) 2001-07-18
WO1995028927A1 (fr) 1995-11-02
ES2152485T3 (es) 2001-02-01
NO310703B1 (no) 2001-08-20
BR9507502A (pt) 1997-09-02
US6051255A (en) 2000-04-18
HU9602922D0 (en) 1996-12-30
SA95160343B1 (ar) 2005-05-04
DE69519093T2 (de) 2001-07-19
ZA953236B (en) 1995-12-27
SK135496A3 (en) 1997-05-07
FI964249A7 (fi) 1996-10-22
ATE223706T1 (de) 2002-09-15
NO964488L (no) 1996-12-17
JPH09512027A (ja) 1997-12-02
HK1036404A1 (en) 2002-01-04
CZ294168B6 (cs) 2004-10-13
DK0761218T3 (da) 2000-12-18
EP0761218A1 (fr) 1997-03-12
PT1093813E (pt) 2003-02-28
PT978276E (pt) 2003-01-31
DE29522153U1 (de) 2000-04-06
HK1009936A1 (en) 1999-06-11
HU228399B1 (en) 2013-03-28
AU684949B2 (en) 1998-01-08
SK282594B6 (sk) 2002-10-08
ATE203161T1 (de) 2001-08-15
PT761218E (pt) 2001-03-30
NO964488D0 (no) 1996-10-22
SI0758235T1 (en) 2001-10-31
DZ1876A1 (fr) 2002-02-17
EP0978276A3 (fr) 2000-04-12
DE69521799T2 (de) 2002-06-13
GR3035031T3 (en) 2001-03-30
JP3622975B2 (ja) 2005-02-23
EP0761218B1 (fr) 2000-10-11
AU2406895A (en) 1995-11-16
DK0978276T3 (da) 2003-01-20
EP0758235A1 (fr) 1997-02-19
ATE226074T1 (de) 2002-11-15
CA2188496A1 (fr) 1995-11-02
GR3036844T3 (en) 2002-01-31
FI964249L (fi) 1996-10-22
AP9600868A0 (en) 1996-10-31
MA23528A1 (fr) 1995-12-31
DK1093813T3 (da) 2003-02-17
RO116997B1 (ro) 2001-09-28
EP1093813A3 (fr) 2001-05-30
ES2182754T3 (es) 2003-03-16
MY115351A (en) 2003-05-31
EP1243267A3 (fr) 2002-10-30
PL316966A1 (en) 1997-03-03
HUT76335A (en) 1997-08-28
AT5350U1 (de) 2002-06-25
BG100933A (en) 1997-07-31
EP1093813A2 (fr) 2001-04-25
DE69528204D1 (de) 2002-10-17

Similar Documents

Publication Publication Date Title
AP564A (en) Polymer coated tablet comprising amoxycillin and clavulanate.
WO2008144730A2 (fr) Formulation pharmaceutique stable pour un inhibiteur de dpp-iv
WO2005099672A1 (fr) Formulation pharmaceutique a liberation modifiee contenant de l'amoxicilline et du clavulanate
WO2008029351A2 (fr) Formulation à libération modifiée comprenant de l'amoxicilline et un clavulanate
HK1009936B (en) Polymer coated tablet comprising amoxycillin and clavulanate
HK1027024B (en) Polymer coated tablet comprising amoxycillin and clavunalate
HK1036404B (en) Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK1021860B (en) Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
MXPA96005055A (en) Polymer revestible tablet that comprises amoxicillin and clavulan